- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.06. | Autonomix Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.06. | Autonomix Medical kündigt Aktienzusammenlegung im Verhältnis 1:21 an | 3 | Investing.com Deutsch | ||
| 18.06. | Autonomix Medical announces 1-for-21 reverse stock split | 2 | Investing.com | ||
| AUTONOMIX MEDICAL Aktie jetzt für 0€ handeln | |||||
| 18.06. | Autonomix Medical, Inc.: Autonomix Announces Reverse Stock Split | 151 | GlobeNewswire (Europe) | THE WOODLANDS, TX, June 18, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted... ► Artikel lesen | |
| 15.06. | Autonomix Medical, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 10.06. | Autonomix Medical, Inc.: Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology | 1 | GlobeNewswire (USA) | ||
| 04.06. | Autonomix Medical executive discusses cancer pain treatment data | 1 | Investing.com | ||
| 04.06. | Autonomix Medical, Inc.: Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine | 2 | GlobeNewswire (USA) | ||
| 27.05. | Autonomix Medical, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 19.05. | Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation | 250 | GlobeNewswire (Europe) | Technology unlocks minimally invasive transvascular access to nerve targets and tissues through and beyond the lumen wall Patent strengthens intellectual property foundation for next-generation neuromodulation... ► Artikel lesen | |
| 18.05. | Autonomix Medical, Inc.: Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation | 2 | GlobeNewswire (USA) | ||
| 29.04. | Autonomix Medical, Inc.: Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation | 3 | GlobeNewswire (USA) | ||
| 22.04. | Autonomix Medical, Inc.: Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026 | 1 | GlobeNewswire (USA) | ||
| 08.04. | Autonomix Medical, Inc.: Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026 | 1 | GlobeNewswire (USA) | ||
| 02.04. | Autonomix Medical, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 11.03. | Autonomix Medical, Inc.: Autonomix Medical to Present at LSI USA '26 | 3 | GlobeNewswire (USA) | ||
| 05.03. | Autonomix Medical, Inc.: Autonomix Medical Selected for Best Innovation Competition at CRT 2026 | 1 | GlobeNewswire (USA) | ||
| 04.03. | Autonomix Medical, Inc.: Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis | 1 | GlobeNewswire (USA) | ||
| 25.02. | Autonomix Medical, Inc.: Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation | 1 | GlobeNewswire (USA) | ||
| 19.02. | Autonomix Medical, Inc.: Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation | 1 | GlobeNewswire (USA) |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 40,330 | +0,90 % | FRESENIUS SE & CO KGAA: Stärke im Gleichgewicht | ||
| SIEMENS HEALTHINEERS | 33,790 | -1,20 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Siemens Healthineers mit einem Kursziel von 50 Euro auf "Buy" belassen. Vorab-Aussagen des Medizinkonzerns zu... ► Artikel lesen | |
| GERRESHEIMER | 29,180 | +4,89 % | Aktien - Shortseller-Positionen: Brenntag, Eventim, Delivery Hero, Gerresheimer, Heidelberger Druck, LPKF, TUI | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| DRAEGERWERK | 83,20 | +0,85 % | EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 der Verordnung (EU) Nr. 596/2014 i.V.m. Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052 der Kommission | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Sonstiges
Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 der Verordnung (EU) Nr. 596/2014 i.V.m. Art. 2 Abs. 1... ► Artikel lesen | |
| INTUITIVE SURGICAL | 351,05 | +0,88 % | Intuitive Surgical's Moat Is Getting Stronger. Is This the Closest Thing to a 'Forever' Stock? | ||
| THERMO FISHER | 440,90 | +0,59 % | Zwei Dividenden-Dauerläufer: Wie Thermo Fisher und Mastercard laut Seeking Alpha lebenslanges Einkommen ermöglichen sollen | Thermo Fisher Scientific und Mastercard werden von Seeking Alpha als zwei qualitativ hochwertige Dividendenwachstumswerte herausgestellt, die sich für ein langfristig orientiertes Dividendeneinkommen... ► Artikel lesen | |
| HIMS & HERS HEALTH | 30,620 | +0,92 % | Hims & Hers-Aktie +162%: Bereit für den nächsten Schub? | Die Hims & Hers-Aktie bleibt eine der spannendsten Turnaround-Storys im US-Healthcare-Sektor. Nach starker Erholung mitsamt Bruch des vorherigen Abwärtstrends konnten vom Februartief bis zum Junihoch... ► Artikel lesen | |
| OTTOBOCK | 51,40 | +1,18 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock beruft Dr. Katarzyna Mazur-Hofsaess in den Verwaltungsrat | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): Personalie
Ottobock beruft Dr. Katarzyna Mazur-Hofsaess in den Verwaltungsrat
24.06.2026 / 11:30 CET/CEST
Für den Inhalt... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,013 | -5,71 % | NuGen Medical Devices Inc.: NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance | Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,770 | +3,51 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| NETRAMARK | 0,420 | +9,66 % | NetraMark Holdings Inc.: NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company | This agreement represents NetraMark's ninth commercial contract since the start of its current fiscal year and demonstrates growing interest in AI-enabled clinical trial analytics, like NetraAI, among... ► Artikel lesen | |
| INSULET | 134,05 | +0,52 % | Deutsche Bank: DexCom und Insulet als Top-Picks im Gesundheitssektor | ||
| BRIGHTSPRING HEALTH SERVICES | 69,76 | +0,03 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 29,330 | -0,03 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,830 | +0,08 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen |
AUTONOMIX MEDICAL INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,050 (-0,80 %) liegt der Kurs bei 6,180 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AUTONOMIX MEDICAL INC finden Sie auf Wallstreet Online.